Biosimilar substitution: European prescriber perspectives

Patient Perspectives on Biosimilar Insulin.

Given that a new wave of biosimilar insulins will likely enter the market in coming years, it is important to understand patient perspectives on these biosimilars. A survey (N = 3214) conducted by the market research company dQ&A, which maintains a 10 000-patient panel of people with type 1 or type 2 diabetes in roughly equal measure, investigated these perspectives. The survey asked whether pa...

Biosimilar insulins: a European perspective

Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the concept of biosimilarity and how a biosimilar drug may differ from its reference product. The present article provides an overview of biosimilars, the European regulatory requirements for biosimilars and safety issues. It also summarizes th...

Biosimilar insulins: current and future perspectives

Analyzing the European Union citizenship through feminist perspectives

The European Union has aspired to create an “ever closer union” among its people since the articulation of the European Union citizenship has been an important instrument towards it. However, attempts at creating this “ever closer union” have focused on homogenizing European citizens as a single entity without taking into account the heterogeneous differentials among such citizens. Gender diffe...

European Perspectives in Cardiology

T Estonian Science Foundation awards grants for research projects in basic and applied research. Grants are for ≤4 years. Applicants (permanent residents of Estonia and citizens of other countries provided that their application is submitted through an Estonian institution) should have a doctoral degree from Estonia or an equivalent academic degree within the past 5 years and should have publis...